Evidence map›Paper›PMID 37103327›Full record

ArticleJournal of functional biomaterials2023

Pharmacological Evaluation of

Aisha M H Al-Rajhi, Husam Qanash, Abdulrahman S Bazaid, Naif K Binsaleh, Tarek M Abdelghany

Open access · goldAbstract read
In one paragraph

Article in Journal of functional biomaterials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Selective anticancer activity ofFrontiers in nutrition · 2026
    Article
  4. Article
  5. Antimicrobial and Synergistic Activity of Metformin AgainstThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  6. Article
  7. Towards EffectiveInternational journal of molecular sciences · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in microbiology · 2025
    Article
  15. Therapeutic advances and future directions inFrontiers in microbiology · 2025
    Review
  16. Article
  17. Opportunities forMicroorganisms · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Aisha M H Al-RajhiDepartment of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Husam QanashDepartment of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha'il, P.O. Box 84428, Hail 55476, Saudi Arabia.ORCID 0000-0002-3068-0313
Abdulrahman S BazaidDepartment of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha'il, P.O. Box 84428, Hail 55476, Saudi Arabia.ORCID 0000-0002-5884-0278
Naif K BinsalehDepartment of Medical Laboratory Science, College of Applied Medical Sciences, University of Ha'il, P.O. Box 84428, Hail 55476, Saudi Arabia.
Tarek M AbdelghanyBotany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo 11725, Egypt.ORCID 0000-0001-6418-5890
University of Ha'il · SAAl-Azhar University · EGPrincess Nourah bint Abdulrahman University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The resistance of cancer and

Indexed as

Acacia niloticaflowersHelicobacter pylorihepatocellular carcinomain silico

Identifiers

PMID37103327
PMCPMC10143343
OpenAlexW4366770863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.